Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.24.1.1.u2
Note 8 - Accrued Liabilities
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Accrued liabilities
8.
Accrued liabilities:

Accrued liabilities as of March 31, 2024 and December 31, 2023 consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Accrued personnel related costs

 

$

1,144

 

 

$

1,989

 

Accrued research and development expenses

 

 

8,052

 

 

 

6,527

 

Other accrued expenses

 

 

123

 

 

 

313

 

Total

 

$

9,319

 

 

$

8,829